These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8180015

  • 1. The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.
    Bokemeyer C, Schmoll HJ, Ludwig E, Harstrick A, Dunn T, Casper J.
    Br J Cancer; 1994 May; 69(5):863-7. PubMed ID: 8180015
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
    Scheulen ME, Niederle N, Bremer K, Schütte J, Seeber S.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():93-101. PubMed ID: 6414700
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M.
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [Abstract] [Full Text] [Related]

  • 6. Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomas.
    Niederle N, Scheulen ME, Cremer M, Schütte J, Schmidt CG, Seeber S.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():129-35. PubMed ID: 6627239
    [Abstract] [Full Text] [Related]

  • 7. Treatment of advanced malignancies with ifosfamide under protection with mesna.
    Li GC, Brock N, Li JQ, Guan ZZ, He YJ.
    Int J Clin Pharmacol Res; 1988 Sep; 8(1):55-67. PubMed ID: 3130316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro studies on interaction of 4-hydroperoxyifosfamide and 2-mercaptoethanesulphonate in malignant gliomas.
    Jäger AH, Bogdahn U, Apfel R, Pfeufer B, Dekant A.
    J Cancer Res Clin Oncol; 1993 Sep; 119(12):721-6. PubMed ID: 8408185
    [Abstract] [Full Text] [Related]

  • 12. Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
    Bokemeyer C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H, Lentzen H.
    Br J Cancer; 1996 Dec; 74(12):2036-41. PubMed ID: 8980410
    [Abstract] [Full Text] [Related]

  • 13. Ifosfamide and mesna.
    Med Lett Drugs Ther; 1989 Nov 03; 31(804):98-9. PubMed ID: 2554100
    [No Abstract] [Full Text] [Related]

  • 14. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
    Cervellino JC, Araujo CE, Pirisi C, Francia A, Cerruti R.
    Oncology; 1991 Nov 03; 48(2):89-92. PubMed ID: 1900124
    [Abstract] [Full Text] [Related]

  • 15. Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinoma.
    Turrill M, Spicer DV, Kelley AS, Herman RL, Russell CA, Muggia FM.
    Cancer Invest; 1995 Nov 03; 13(2):160-4. PubMed ID: 7874569
    [Abstract] [Full Text] [Related]

  • 16. A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study.
    Zidar BL, Metch B, Balcerzak SP, Pierce HI, Militello L, Keppen MD, Berenberg JL.
    Cancer; 1992 Nov 15; 70(10):2547-51. PubMed ID: 1423183
    [Abstract] [Full Text] [Related]

  • 17. Ifosfamide and mesna.
    Schoenike SE, Dana WJ.
    Clin Pharm; 1990 Mar 15; 9(3):179-91. PubMed ID: 2107997
    [Abstract] [Full Text] [Related]

  • 18. Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study.
    Specenier P, Rasschaert M, Van den Brande J, Dyck J, Schrijvers D, Huizing MT, Vermorken JB.
    Anticancer Drugs; 2010 Mar 15; 21(3):306-12. PubMed ID: 20087171
    [Abstract] [Full Text] [Related]

  • 19. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
    Miser JS, Kinsella TJ, Triche TJ, Tsokos M, Jarosinski P, Forquer R, Wesley R, Magrath I.
    J Clin Oncol; 1987 Aug 15; 5(8):1191-8. PubMed ID: 3114435
    [Abstract] [Full Text] [Related]

  • 20. Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide.
    Kuśnierczyk H, Konarski L, Kowalski P, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1997 Aug 15; 45(1):79-85. PubMed ID: 9090445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.